Healthcare: This Drug Pricing Scheme Could Be...

We're moving over to a new show! Here's a sneak peek of what to expect when Motley Fool Money goes daily on January 5, 2022. Subscribe here on Spotify Subscribe here on Apple Podcasts 

Nick, Emily, Jason, and Dylan get together to talk through the companies they've learned the most from, the stocks they've sold recently (and why!) and also where you can catch all of them with The Motley Fool's new audio offering in 2022. Stocks: MELI, SHOP, GME, BBY Check out m ...  Show more

If you had a rare disease and the only drug that could help you suddenly shot up in price how would you feel? What if your health service or insurer decided it was too expensive and they wouldn’t fund it any more? This is the problem facing some patients in the Netherlands.In ord ...  Show more

John Green recently made a video asking Johnson & Johnson not to extend their patent on a tuberculosis drug, which would keep it exclusive and expensive. Dr. Sydnee and Justin talk about how drug patents work, the recent (good) update about bedaquiline specifically, and the ne ...

Parkinson’s patients derived more benefits from a salt solution they were told was an expensive drug than from the same solution when it was described as being cheap medication. Karen Hopkin reports 

It's hard to put a value on a human life. When you're well, perhaps you don't think about it. But if you're ill, getting access to the right drugs, whatever the cost, is a priority. But the NHS does not have a bottomless pit of money. And some medicines are judged too expensive t ...  Show more